¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"radionuclide ejection fraction"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • midsystolic ejection click
    ¼öÃàÁß±â¹ÚÃâ°±ïÀ½
  • milk ejection reflex
    Á¥ºÐÃâ¹Ý»ç
  • ventricular ejection
    ½É½Ç¹ÚÃâ
  • attributable fraction
    ±â¿©ºÐÀ²
  • absorbed fraction
    Èí¼öºÐÀ²
  • etiologic fraction
    ¿øÀκÐÀ²
  • filtration fraction
    ¿©°úºÐÀ², °Å¸£±âºÐÀ²
  • fraction
    1. ºÐ¼ö, ºÐÀ² 2. ºÎºÐ 3. ºÐȹ, ºÐÇÒ
  • fraction of inspired oxygen
    ÈíÀÔ»ê¼Ò³óµµ
  • growth fraction
    ¼ºÀåºÐÀ²
  • hypoxic fraction
    Àú»ê¼ÒºÐȹ
  • human plasma protein fraction
    »ç¶÷Ç÷Àå´Ü¹éºÐÀ²
  • inspired oxygen fraction
    µé¼û»ê¼ÒºÐÀ², Èí±â»ê¼ÒºÐÀ²
  • mole fraction
    ¸ôºÐÀ²
  • motor unit fraction
    ¿îµ¿´ÜÀ§ºÐȹ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • ventricular ejection
    ½É½Ç¹ÚÃâ
  • milk ejection reflex
    Á¥ºÐÃâ¹Ý»ç
  • absorbed fraction
    Èí¼öºÐÀ²
  • attributable fraction
    ±â¿©ºÐÀ²
  • fraction collector
    ºÐȹ¼öÁý±â
  • etiologic fraction
    ¿øÀκÐÀ²
  • fraction
    ºÎºÐ, ºÐÀ², ºÐȹ
  • filtration fraction
    °Å¸£±âºÐÀ², ¿©°úºÐÀ²
  • growth fraction
    ¼ºÀåºÐÀ²
  • hypoxic fraction
    Àú»ê¼ÒºÐȹ
  • inspired oxygen fraction
    Èí±â»ê¼ÒºÐÀ²
  • mole fraction
    ¸ôºÐÀ²
  • motor unit fraction
    ¿îµ¿´ÜÀ§ºÐȹ
  • volume fraction
    ºÎÇǺÐÀ², ¿ëÀûºÐÀ²
  • tubular rejection fraction ratio
    ÄáÆÏ´¢¼¼°ü°ÅºÎºÐȹ·ü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • inspired oxygen fraction
    Èí±â»ê¼ÒºÐÀ²
  • plasma protein fraction =PCC
    Ç÷Àå´Ü¹éºÐȹ
  • recombination fraction
    ÀçÁ¶Çպмö(î¢ðàùêÝÂâ¦)
  • reducible fraction
    ¹Ì¾àºÐ¼ö(Ú±å³ÝÂâ¦).
  • reduction of fraction
    ¾àºÐ(å³ÝÂ).
  • regurgitant fraction
    ¿ª·ùºÐȹ.
  • renal fraction
    ½ÅºÐÀ².
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • ejection murmur
    ¹ÚÃ⼺(ÚÑõóàõ) ÀâÀ½(íÚëå).
  • ejection murmur
    ¹ÚÃ⼺ ÀâÀ½.
  • ejection period
    ¹ÚÃâ±â(ÚÑõóÑ¢).
  • ejection period
    ¹ÚÃâ±â.
  • ejection phase
    ¹ÚÃâ±â(ÚÑõóÑ¢).
  • ejection phase
    ¹ÚÃâ±â.
  • ejection sound
    ¹ÚÃâÀ½.
  • ejection time
    ¹ÚÃâ½Ã°£(ÚÑõóãÁÊà).
  • left ventricular ejection time
    Á½ɽDZ¸Ç÷±â°£(¡­ÏÌúìÑ¢Êà).
  • maximal ejection phase
    Ãִ뱸Ãâ±â(¡­ÏÌõóÑ¢).
  • milk ejection reflex
    »çÀ¯¹Ý»ç
  • ventricular ejection
    ½É½Ç¹ÚÃâ
  • absorbed fraction
    Èí¼öºÐÀ²
  • early labeled fraction
    Á¶±âÇ¥ÁöºÐȹ(¡­øöãÛÝÂüñ).
  • etiologic fraction
    ¿øÀÎÀû ¿ä¼Ò
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • saponifiable fraction
    °¡(ʦ)ºñ´©È­ ºÐȹ(ÝÂüñ)
  • saturation fraction
    Æ÷È­ ºÐȹ(øéûùÝÂüñ)
  • S-100 fraction
    S-100 ºÐȹ(ÝÂüñ)
  • soluble fraction
    °¡¿ë ºÐȹ(ʦéÁÝÂüñ)
  • subcellular fraction
    ¼¼Æ÷ÇÏ ºÐȹ(á¬øàù»ÝÂüñ)
  • volume fraction
    ¿ëÀû ºÐȹ(é»îÝÝÂüñ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
REFI regional ejection fraction image
RVEF right ventricular ejection fraction; right ventricular end-flow
VEF ventricular ejection fraction; visually evoked field
XEF excess ejection fraction
EF Ejection fraction
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
LVEF Left Ventricular Ejection Fraction
RVEF RV ejection fraction
REF Regional ejection fraction
RVEF Right Ventricular Ejection Fraction
LVEF left ventricle ejection fraction
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • serum cholesterol fraction
    Ç÷û ÄÝ·¹½ºÅ×·Ñ ºÐȹ
    Ç÷û Áß ÃÑÄÝ·¹½ºÅ×·ÑÀº Æò±Õ 200mg 100ml ¿¡½ºÅÍÈ­µÇÁö ¾ÊÀº À¯¸®ÇÑ ÄÝ·¹½ºÅ×·ÑÀº Æò±Õ 55mgÀÌ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
radionuclide scan An exam that produces pictures (scans) of internal parts of the body. The patient is given an injection or swallows a small amount of radioactive material. A machine called a scanner then measures the radioactivity in certain organs.
(12 Dec 1998)
radionuclide ventriculography Imaging of a ventricle of the heart after the injection of a radioactive contrast medium. The technique is less invasive than cardiac catheterization and is used to assess ventricular function.
(12 Dec 1998)
gated radionuclide angiocardiography Radionuclide angiocardiography using cardiac gating to combine images from several cardiac cycles to improve the quality of the images of separate phases (e.g., systole and diastole).
(05 Mar 2000)
exercise radionuclide angiocardiography Radionuclide angiocardiography while performing exercise, such as on a treadmill or bicycle.
(05 Mar 2000)
aetiological fraction <epidemiology> The reduction in disease when a risk factor is removed. If I* is the number of people that a risk factor is responsible for and I is the total number of cases over the same period, then the aetiological fraction is I*/I. Equivalently, the aetiological fraction is (I-Io)/I. Where Io is the number of cases in the absence of the risk factor. Also known as the attributable fraction.
(05 Dec 1998)
amorphous fraction of adrenal cortex Noncrystalline residue of an acetone extract of the adrenal cortex after crystalline steroids, e.g., corticosterone, deoxycorticosterone, etc., have been isolated.
(05 Mar 2000)
attributable fraction <epidemiology> The same as aetiological fraction.
(05 Dec 1998)
recombination fraction The proportion of progeny of a mating pair of specific genotype and coupling phase that are recombinant; there must be no differential selection among the possible types of progeny, and the recombination fraction should be the same regardless of the alleles involved or their coupling phase.
(05 Mar 2000)
regurgitant fraction The amount of blood regurgitated into a cardiac chamber divided by the stroke output; normally, no blood regurgitates; in patients with severe valvular lesions such as mitral or aortic insufficiency, regurgitation can approach 80%; this fraction affords a quantitative measure of the severity of the valvular lesion.
(05 Mar 2000)
microsomal fraction Artifactual vesicles formed from the endoplasmic reticulum when cells are disrupted. They are isolated by differential centrifugation and are composed of three structural features: rough vesicles, smooth vesicles, and ribosomes. Numerous enzyme activities are associated with the microsomal fraction. (glick, glossary of biochemistry and molecular biology, 1990; from rieger et al., glossary of genetics: classical and molecular, 5th ed)
(12 Dec 1998)
mole fraction The ratio of the moles of one component of a system to the total moles of all the components present.
(05 Mar 2000)
human antihemophilic fraction A lyophilised concentrate of factor VIII, obtained from fresh normal human plasma; used as a haemostatic agent in haemophilia.
Synonym: antihemophilic globulin, human antihemophilic fraction.
(05 Mar 2000)
human plasma protein fraction A sterile solution of selected proteins derived from the blood plasma of adult human donors, containing 4.5 to 5.5 g of protein per 100 ml, of which 83 to 90% is albumin and the remainder is alpha-and beta-globulins; used as a blood volume supporter.
(05 Mar 2000)
dried human plasma protein fraction Freeze-dried human plasma protein fraction.
(05 Mar 2000)
filtration fraction The fraction of the plasma entering the kidney that filters into the lumen of the renal tubules, determined by dividing the glomerular filtration rate by the renal plasma flow; normally, it is around 0.17.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • proper fraction
    ÁøºÐ¼ö
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á